Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Modulating tumour metabolism enhances gold nanoparticle radiosensitisation in HPV-negative head and neck cancer

Fig. 5

Cell cycle distribution of HNSCC cells 24 h after treatment with AuNPs (100 μg) and/or atovaquone (AQ 30 μM), alone or in combination with radiation (4 Gy) under both 21% O2 and hypoxic conditions (0.5% O2). One-way ANOVA followed by Turkey’s multiple tests was used to compare within different treatments, significant differences are represented by *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Data were obtained from three independent experiments performed in triplicate ± SEM

Back to article page